Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -444.8 K-269.81 K-225.58 K-255.5 K-456.54 K-261.96 K -1.2 M Non-Operating Income, Total 2.1 M2.14 M2.19 M2.04 M1.85 M1.87 M 7.95 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 2.1 M2.14 M2.19 M2.04 M1.85 M1.87 M 7.95 M Unusual income/expense —————— — Pretax income 1.66 M1.87 M1.97 M1.79 M1.39 M1.6 M 6.75 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.66 M1.87 M1.97 M1.79 M1.39 M1.6 M 6.75 M Discontinued operations —————— — Net income 1.66 M1.87 M1.97 M1.79 M1.39 M1.6 M 6.75 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.66 M1.87 M1.97 M1.79 M1.39 M1.6 M 6.75 M Basic earnings per share (Basic EPS) 0.060.070.080.080.050.07 0.28 Diluted earnings per share (Diluted EPS) 0.060.070.080.080.050.07 0.28 Average basic shares outstanding 5.38 M5.38 M5.38 M5.38 M5.38 M5.38 M — Diluted shares outstanding -10.77 M5.38 M5.38 M5.38 M5.38 M5.38 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —